Tanke Biosciences (TNBI) Financial Statements
Tanke Biosciences Financial Overview
Tanke Biosciences's market cap is currently $677.24K. The company's EPS TTM is $-0.01; its P/E ratio is -3.95; Tanke Biosciences has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 8.43K | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ 6.87K | $ -977.00 | $ -8.50K | $ 0.00 | $ 0.00 |
| Operating Income | $ -257.87K | $ -117.42K | $ -94.16K | $ -128.18K | $ -668.03K |
| EBITDA | $ -256.30K | $ -116.44K | $ -18.25K | $ 0.00 | $ -53.02K |
| Net Income | $ -274.46K | $ -119.93K | $ -82.52K | $ -98.15K | $ -722.98K |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 6.01K | $ 0.00 | $ 2.66K | $ 7.32K | $ 41.49K |
| Total Assets | $ 74.47K | $ 65.52K | $ 69.16K | $ 7.32K | $ 41.49K |
| Total Debt | $ 140.00K | $ 140.00K | $ 140.00K | $ 53.03K | $ 1.79K |
| Net Debt | $ 133.99K | $ 140.00K | $ 137.34K | $ 45.71K | $ -39.70K |
| Total Liabilities | $ 473.28K | $ 248.86K | $ 164.81K | $ 95.45K | $ 101.48K |
| Stockholders' Equity | $ -398.81K | $ -183.34K | $ -95.66K | $ -88.13K | $ -59.98K |
| Cash Flow | |||||
| Free Cash Flow | $ -36.99K | $ -34.90K | $ -74.66K | $ -59.18K | $ -3.53K |
| Operating Cash Flow | $ -36.99K | $ -34.90K | $ -74.66K | $ -59.18K | $ -3.53K |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Financing Cash Flow | $ 43.00K | $ 32.24K | $ 70.00K | $ 25.00K | $ 45.02K |
Currency in USD
